Last reviewed · How we verify
Clorhexidine-Chitosan gel
Clorhexidine-Chitosan gel is a Small molecule drug developed by University of Santiago de Compostela. It is currently FDA-approved. Also known as: Bexident Post.
At a glance
| Generic name | Clorhexidine-Chitosan gel |
|---|---|
| Also known as | Bexident Post |
| Sponsor | University of Santiago de Compostela |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Clorhexidine-Chitosan gel CI brief — competitive landscape report
- Clorhexidine-Chitosan gel updates RSS · CI watch RSS
- University of Santiago de Compostela portfolio CI
Frequently asked questions about Clorhexidine-Chitosan gel
What is Clorhexidine-Chitosan gel?
Clorhexidine-Chitosan gel is a Small molecule drug developed by University of Santiago de Compostela.
Who makes Clorhexidine-Chitosan gel?
Clorhexidine-Chitosan gel is developed and marketed by University of Santiago de Compostela (see full University of Santiago de Compostela pipeline at /company/university-of-santiago-de-compostela).
Is Clorhexidine-Chitosan gel also known as anything else?
Clorhexidine-Chitosan gel is also known as Bexident Post.
What development phase is Clorhexidine-Chitosan gel in?
Clorhexidine-Chitosan gel is FDA-approved (marketed).
Related
- Manufacturer: University of Santiago de Compostela — full pipeline
- Also known as: Bexident Post
- Compare: Clorhexidine-Chitosan gel vs similar drugs
- Pricing: Clorhexidine-Chitosan gel cost, discount & access